SANTEN PHARMACEUTICAL CO.,LTD. Logo

SANTEN PHARMACEUTICAL CO.,LTD.

A global company specializing in pharmaceuticals and medical devices for ophthalmology.

4536 | T

Overview

Corporate Details

ISIN(s):
JP3336000009
LEI:
Country:
Japan
Address:
大阪市北区大深町4番20号

Description

Santen Pharmaceutical Co., Ltd. is a global company specializing in ophthalmology. It is engaged in the research, development, manufacturing, sales, and marketing of pharmaceutical products and medical devices dedicated to eye health. The company's portfolio includes prescription and over-the-counter pharmaceuticals that address a wide range of ophthalmic conditions. Serving patients, consumers, and medical professionals in over 60 countries, Santen aims to contribute to the realization of “Happiness with Vision” by providing valuable products and services worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-15 06:37
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 24.5 KB
2025-11-14 01:56
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 25.9 KB
2025-11-10 07:02
確認書
Japanese ZIP 8.7 KB
2025-11-10 07:01
半期報告書-第114期(2025/04/01-2026/03/31)
Japanese ZIP 366.6 KB
2025-10-15 03:28
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 24.2 KB
2025-09-12 04:58
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 25.9 KB
2025-08-13 03:24
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 25.8 KB
2025-07-15 04:38
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 25.2 KB
2025-06-25 04:08
臨時報告書
Japanese ZIP 26.5 KB
2025-06-24 09:22
臨時報告書
Japanese ZIP 32.1 KB
2025-06-23 08:29
内部統制報告書-第113期(2024/04/01-2025/03/31)
Japanese ZIP 24.3 KB
2025-06-23 08:28
確認書
Japanese ZIP 8.5 KB
2025-06-23 08:27
有価証券報告書-第113期(2024/04/01-2025/03/31)
Japanese ZIP 2.2 MB
2025-06-13 04:35
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 22.1 KB
2025-04-15 06:53
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 21.3 KB

Automate Your Workflow. Get a real-time feed of all SANTEN PHARMACEUTICAL CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SANTEN PHARMACEUTICAL CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SANTEN PHARMACEUTICAL CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Develops and manufactures biologic medicines, including biosimilars and novel drugs.
South Korea
007460
Develops drugs for intractable diseases by regulating oxidative stress and CAFs.
South Korea
293780
Aptamer Sciences Inc Logo
Clinical-stage company developing aptamer-based therapeutics for oncology.
South Korea
291650
Aptorum Group Ltd Logo
Clinical-stage biopharma developing therapeutics for oncology and infectious diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Pharmaceutical company developing oral film medicines for CNS and allergic reactions.
United States of America
AQST
Arbutus Biopharma Corp Logo
Clinical-stage biopharma company developing a functional cure for chronic Hepatitis B.
United States of America
ABUS
Arcellx, Inc. Logo
A clinical-stage biotech company developing immunotherapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharmaceutical and nutraceutical products from marine membrane lipids.
Norway
ABS
ArcticZymes Technologies Logo
Develops and manufactures novel recombinant enzymes from Arctic marine organisms.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
A commercial-stage mRNA medicines company focused on rare and infectious diseases.
United States of America
ARCT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.